{
    "clinical_study": {
        "@rank": "56832", 
        "arm_group": [
            {
                "arm_group_label": "Nicotrol Inhaler", 
                "arm_group_type": "Experimental", 
                "description": "Nicotrol Inhaler, 1-12 cartridges per day, for 6 weeks with a 6 week taper."
            }, 
            {
                "arm_group_label": "Placebo Inhaler", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo inhaler, 1-12 cartridges per day, for 6 weeks with a 6 week taper"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a clinical trial to determine if the nicotine inhaler in combination with counseling\n      will help pregnant women quit smoking, and whether it is safe when compared to placebo (an\n      inactive inhaler)."
        }, 
        "brief_title": "Nicotine Replacement for Smoking Cessation During Pregnancy", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Nicotine Dependence", 
            "Smoking Cessation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Tobacco Use Disorder", 
                "Smoking"
            ]
        }, 
        "detailed_description": {
            "textblock": "This project will examine the safety and efficacy of the nicotine inhaler as an aid to\n      smoking cessation during pregnancy. The specific aims are: (1) To examine the efficacy of\n      the nicotine inhaler compared to a matching placebo for smoking cessation during pregnancy;\n      (2) To compare the nicotine inhaler with placebo on overall nicotine exposure (i.e., serum\n      cotinine concentrations), and on birth outcomes (i.e., birth weight and gestational age);\n      (3) To identify factors that determine which women benefit most from the use of the nicotine\n      inhaler for smoking cessation during pregnancy; (4) To explore mechanisms by which the\n      nicotine inhaler increases birth weight and gestational age.\n\n      Subjects will be recruited from two prenatal clinics that serve primarily a low-income,\n      minority population.\n\n      Pregnant smokers (n=270) who smoke at least 5 cigarettes/ day will receive nurse-delivered\n      behavioral counseling and be randomized to receive a 6-week course of treatment with either\n      a nicotine inhaler or placebo, followed by a 6-week taper. Birth outcomes will be obtained\n      on all participants"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  smoking at least 5 cigarettes per day for the preceding 7 days\n\n          -  previous attempt to quit smoking during pregnancy by self report\n\n          -  13-26 weeks gestation\n\n          -  at least 16 years of age\n\n          -  able to speak English or Spanish\n\n          -  intent to carry pregnancy to term\n\n          -  stable residence\n\n        Exclusion Criteria:\n\n          -  current drug or alcohol abuse or dependence (other than methadone maintenance)\n\n          -  twins or other multiple gestation\n\n          -  unstable psychiatric disorder\n\n          -  unstable medical problems (e.g., pre-eclampsia, threatened abortion, hyperemesis\n             gravidarum)\n\n          -  known congenital abnormality"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "360", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01656733", 
            "org_study_id": "11-057-6", 
            "secondary_id": "1R01HD069314-01A1"
        }, 
        "intervention": {
            "arm_group_label": [
                "Nicotrol Inhaler", 
                "Placebo Inhaler"
            ], 
            "description": "Nicotrol Inhaler, 1-12 cartridges per day, for 6 weeks with a 6 week taper Placebo Inhaler, 1-12 cartridges per day, for 6 weeks with a 6 week taper.", 
            "intervention_name": "Nicotrol Inhaler", 
            "intervention_type": "Drug", 
            "other_name": [
                "Nicitine Inhaler", 
                "Placebo Inhaler"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Smoking Cessation", 
            "Pregnancy", 
            "Nicotrol Inhaler", 
            "Placebo Inhaler", 
            "Nicotine Inhaler"
        ], 
        "lastchanged_date": "June 19, 2013", 
        "location": [
            {
                "contact": {
                    "email": "llorson@harthosp.org", 
                    "last_name": "Lindsay Lorson, B.S.", 
                    "phone": "860-545-1295"
                }, 
                "facility": {
                    "address": {
                        "city": "Hartford", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06106"
                    }, 
                    "name": "Women's Ambulatory Health Services at Hartford Hospital"
                }, 
                "investigator": {
                    "last_name": "Ellen Dornelas, Ph.D.", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01199"
                    }, 
                    "name": "Wesson Women's Clinic at Baystate Medical Center"
                }, 
                "investigator": {
                    "last_name": "Heather Sankey, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Nicotine Replacement for Smoking Cessation During Pregnancy", 
        "overall_contact": {
            "email": "thurlow@uchc.edu", 
            "last_name": "Sheila D. Thurlow, M.S.N., R.N.", 
            "phone": "860-679-4637"
        }, 
        "overall_official": {
            "affiliation": "University of Connecticut Health Center", 
            "last_name": "Cheryl Oncken, M.D., M.P.H.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To examine the efficacy of the nicotine inhaler compared to a matched placebo for smoking cessation and reduction among pregnant smokers.", 
            "measure": "7 day point prevalence (PPA)", 
            "safety_issue": "No", 
            "time_frame": "32-34 weeks gestation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01656733"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Connecticut Health Center", 
            "investigator_full_name": "Cheryl Oncken", 
            "investigator_title": "Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "To compare the nicotine inhaler with placebo on safety measures which include a) overall nicotine exposure (i.e. serum cotinine) and birth outcomes (i.e. birth weight and gestational age)", 
                "measure": "Birth weights, gestational age and cotinine concentrations", 
                "safety_issue": "No", 
                "time_frame": "32-34 weeks gestation"
            }, 
            {
                "description": "To identify factors that determine which women benefit most from the use of nicotine inhaler for smoking cessation during pregnancy.", 
                "measure": "Exhaled carbon monoxide and cigarettes per day (CPD)", 
                "safety_issue": "No", 
                "time_frame": "6 weeks and 32-34 weeks gestation"
            }, 
            {
                "description": "To explore mechanisms by which the nicotine inhaler increases birth weight and gestational age.", 
                "measure": "Birth Weight and gestational age", 
                "safety_issue": "No", 
                "time_frame": "32-34 weeks gestation"
            }
        ], 
        "source": "University of Connecticut Health Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Connecticut Health Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}